What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 4.09: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.82%Above 5Y avg (1.61%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
83.5%Moderate
Payback Period
44.2 yr
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
6.89BCNY1.03B · vs all stocks (USD)
Trailing P/E
61.17xRevenue (TTM)
1.10BCNY164.51M · vs all stocks (USD)
Profit Margin
10.34%Beta
0.5090xvs all stocks
52-Week Change
-21.01%vs all stocks
Market Capitalization
6.89BCNY1.03B · vs all stocks (USD)
Enterprise Value
4.61BCNY691.92M · vs all stocks (USD)
Trailing P/E
61.17xPrice to Sales (TTM)
6.28xPrice to Book (MRQ)
1.84xEnterprise to Revenue
4.21xEnterprise to EBITDA
29.75xGross Margin
74.43%Profit Margin
10.34%Operating Margin
2.06%Return on Assets (TTM)
0.75%Return on Equity (TTM)
2.97%Revenue (TTM)
1.10BCNY164.51M · vs all stocks (USD)
Revenue per Share (TTM)
1.76CNYUpdated Oct 24, 2026Quarterly Revenue Growth
32.00%Gross Profit (TTM)
848.47MCNY127.25M · vs all stocks (USD)
EBITDA (TTM)
123.82MCNY18.57M · vs all stocks (USD)
Net Income (TTM)
113.41MCNY17.01M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
18.24%Operating Cash Flow (TTM)
209.10MCNY31.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
13.89MCNY2.08M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Oct 24, 2026Trailing Annual Dividend Yield
1.82%vs all stocks
5-Year Average Dividend Yield
1.61%vs all stocks
Payout Ratio
83.52%Minority Interest (Equity)
-11.25MCNYFY2025 · Dec 31, 2025Revenue
998.14MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
203.60MCNYFY2025 · Dec 31, 2025Gross Profit
794.55MCNYFY2025 · Dec 31, 2025Operating Income
59.51MCNY8.93M · vs all stocks (USD)
Pre-tax Income
-64.31MCNYFY2025 · Dec 31, 2025Income Tax Expense
-33.77MCNYFY2025 · Dec 31, 2025Net Income
-30.55MCNYFY2025 · Dec 31, 2025EBIT
-54.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
211.86MCNYFY2025 · Dec 31, 2025Research & Development
302.71MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
346.56MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
53.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.78MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0405CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0405CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
615.72MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
615.72MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-30.55MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
5.59MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-212.93MCNYFY2025 · Dec 31, 2025Free Cash Flow
-317.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.38BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-30.55MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.13MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-41.96MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-145.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-104.97MCNYFY2025 · Dec 31, 2025Purchase of Investments
-450.82MCNYFY2025 · Dec 31, 2025Sale of Investments
687.18MCNYFY2025 · Dec 31, 2025Other Investing Activity
-600.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
130.79MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
493.15MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-385.10MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-199.07MCNYFY2025 · Dec 31, 2025Other Financing Charges
190.97MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
99.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
625.90MSharesUpdated Oct 24, 2026Float Shares
356.73MSharesUpdated Oct 24, 2026% Held by Insiders
50.72%vs all stocks
% Held by Institutions
4.09%vs all stocks
Total Cash (MRQ)
2.78BCNY416.82M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.46CNYUpdated Oct 24, 2026Total Debt (MRQ)
730.19MCNY109.51M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1964xCurrent Ratio (MRQ)
2.43xBook Value per Share (MRQ)
5.98CNYUpdated Oct 24, 2026Total Assets
5.02BCNY752.82M · vs all stocks (USD)
Total Current Assets
3.17BCNYFY2025 · Dec 31, 2025Total Liabilities
1.27BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.85BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
91.66MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.18BCNYFY2025 · Dec 31, 2025Cash
2.38BCNYFY2025 · Dec 31, 2025Cash Equivalents
25.76MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.40BCNYFY2025 · Dec 31, 2025Other Short-term Investments
278.43MCNYFY2025 · Dec 31, 2025Accounts Receivable
92.33MCNYFY2025 · Dec 31, 2025Inventory
263.75MCNYFY2025 · Dec 31, 2025Accounts Payable
146.14MCNYFY2025 · Dec 31, 2025Short-term Debt
603.23MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
423.60MCNYFY2025 · Dec 31, 2025Retained Earnings
729.58MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.75BCNY561.97M · vs all stocks (USD)
Treasury Stock
30.02MCNYFY2025 · Dec 31, 202552-Week Low
9.61CNYUpdated Oct 24, 202652-Week High
17.33CNYUpdated Oct 24, 202652-Week Change
-21.01%vs all stocks
Beta
0.5090xvs all stocks
50-Day MA
11.79CNYUpdated Oct 24, 2026200-Day MA
12.32CNYUpdated Oct 24, 2026Avg 10-Day Volume
11.27MSharesUpdated Oct 24, 2026Avg 30-Day Volume
11.83MSharesUpdated Oct 24, 2026Diluted EPS (TTM)
0.1800CNYUpdated Oct 24, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.32Receivables vs revenue divergence: 2.56
Financial Health
Altman Z-Score 4.09: safe zoneNotable
Altman Z-Score: 4.09
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shinva Medical Instrument Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ceribell, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Warrants Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sequent Scientific Ltd.
Tier 1ProductionApproval-Gated PipelineRule